ARTELO BIOSCIENCES, INC. Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments
ARTELO BIOSCIENCES, INC. (ARTL) reported Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments of $8.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 · last filed 2023-03-31
- ARTELO BIOSCIENCES, INC. change in unrealized gain (loss) on fair value hedging instruments for fiscal 2021 was $8.00K.
| Period end | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments 12 month |
|---|---|
| 2021-12-31 | $8.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |